Global Single-Domain Antibody Platform Market Insights, Forecast to 2028

Table Of Contents

1 Report Business Overview

1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Single-Domain Antibody Platform Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Multi-Specific Single Domain Antibody 1.2.3 Bispecific Single Domain Antibody 1.2.4 Multivalent Single Domain Antibody 1.2.5 Mono-Specific Single Domain Antibody 1.3 Market by Application 1.3.1 Global Single-Domain Antibody Platform Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Diagnostic Laboratories 1.3.3 Clinical Laboratories 1.3.4 Academic and Research Institutes 1.3.5 Pharmaceutical and Biotechnology Companies 1.4 Study Objectives 1.5 Years Considered2 Global Growth Trends 2.1 Global Single-Domain Antibody Platform Market Perspective (2017-2028) 2.2 Single-Domain Antibody Platform Growth Trends by Region 2.2.1 Single-Domain Antibody Platform Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Single-Domain Antibody Platform Historic Market Size by Region (2017-2022) 2.2.3 Single-Domain Antibody Platform Forecasted Market Size by Region (2023-2028) 2.3 Single-Domain Antibody Platform Market Dynamics 2.3.1 Single-Domain Antibody Platform Industry Trends 2.3.2 Single-Domain Antibody Platform Market Drivers 2.3.3 Single-Domain Antibody Platform Market Challenges 2.3.4 Single-Domain Antibody Platform Market Restraints3 Competition Landscape by Key Players 3.1 Global Top Single-Domain Antibody Platform Players by Revenue 3.1.1 Global Top Single-Domain Antibody Platform Players by Revenue (2017-2022) 3.1.2 Global Single-Domain Antibody Platform Revenue Market Share by Players (2017-2022) 3.2 Global Single-Domain Antibody Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Single-Domain Antibody Platform Revenue 3.4 Global Single-Domain Antibody Platform Market Concentration Ratio 3.4.1 Global Single-Domain Antibody Platform Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Single-Domain Antibody Platform Revenue in 2021 3.5 Single-Domain Antibody Platform Key Players Head office and Area Served 3.6 Key Players Single-Domain Antibody Platform Product Solution and Service 3.7 Date of Enter into Single-Domain Antibody Platform Market 3.8 Mergers & Acquisitions, Expansion Plans4 Single-Domain Antibody Platform Breakdown Data by Type 4.1 Global Single-Domain Antibody Platform Historic Market Size by Type (2017-2022) 4.2 Global Single-Domain Antibody Platform Forecasted Market Size by Type (2023-2028)5 Single-Domain Antibody Platform Breakdown Data by Application 5.1 Global Single-Domain Antibody Platform Historic Market Size by Application (2017-2022) 5.2 Global Single-Domain Antibody Platform Forecasted Market Size by Application (2023-2028)6 North America 6.1 North America Single-Domain Antibody Platform Market Size (2017-2028) 6.2 North America Single-Domain Antibody Platform Market Size by Type 6.2.1 North America Single-Domain Antibody Platform Market Size by Type (2017-2022) 6.2.2 North America Single-Domain Antibody Platform Market Size by Type (2023-2028) 6.2.3 North America Single-Domain Antibody Platform Market Share by Type (2017-2028) 6.3 North America Single-Domain Antibody Platform Market Size by Application 6.3.1 North America Single-Domain Antibody Platform Market Size by Application (2017-2022) 6.3.2 North America Single-Domain Antibody Platform Market Size by Application (2023-2028) 6.3.3 North America Single-Domain Antibody Platform Market Share by Application (2017-2028) 6.4 North America Single-Domain Antibody Platform Market Size by Country 6.4.1 North America Single-Domain Antibody Platform Market Size by Country (2017-2022) 6.4.2 North America Single-Domain Antibody Platform Market Size by Country (2023-2028) 6.4.3 United States 6.4.4 Canada7 Europe 7.1 Europe Single-Domain Antibody Platform Market Size (2017-2028) 7.2 Europe Single-Domain Antibody Platform Market Size by Type 7.2.1 Europe Single-Domain Antibody Platform Market Size by Type (2017-2022) 7.2.2 Europe Single-Domain Antibody Platform Market Size by Type (2023-2028) 7.2.3 Europe Single-Domain Antibody Platform Market Share by Type (2017-2028) 7.3 Europe Single-Domain Antibody Platform Market Size by Application 7.3.1 Europe Single-Domain Antibody Platform Market Size by Application (2017-2022) 7.3.2 Europe Single-Domain Antibody Platform Market Size by Application (2023-2028) 7.3.3 Europe Single-Domain Antibody Platform Market Share by Application (2017-2028) 7.4 Europe Single-Domain Antibody Platform Market Size by Country 7.4.1 Europe Single-Domain Antibody Platform Market Size by Country (2017-2022) 7.4.2 Europe Single-Domain Antibody Platform Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries8 Asia-Pacific 8.1 Asia-Pacific Single-Domain Antibody Platform Market Size (2017-2028) 8.2 Asia-Pacific Single-Domain Antibody Platform Market Size by Type 8.2.1 Asia-Pacific Single-Domain Antibody Platform Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Single-Domain Antibody Platform Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Single-Domain Antibody Platform Market Share by Type (2017-2028) 8.3 Asia-Pacific Single-Domain Antibody Platform Market Size by Application 8.3.1 Asia-Pacific Single-Domain Antibody Platform Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Single-Domain Antibody Platform Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Single-Domain Antibody Platform Market Share by Application (2017-2028) 8.4 Asia-Pacific Single-Domain Antibody Platform Market Size by Region 8.4.1 Asia-Pacific Single-Domain Antibody Platform Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Single-Domain Antibody Platform Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Single-Domain Antibody Platform Market Size (2017-2028) 9.2 Latin America Single-Domain Antibody Platform Market Size by Type 9.2.1 Latin America Single-Domain Antibody Platform Market Size by Type (2017-2022) 9.2.2 Latin America Single-Domain Antibody Platform Market Size by Type (2023-2028) 9.2.3 Latin America Single-Domain Antibody Platform Market Share by Type (2017-2028) 9.3 Latin America Single-Domain Antibody Platform Market Size by Application 9.3.1 Latin America Single-Domain Antibody Platform Market Size by Application (2017-2022) 9.3.2 Latin America Single-Domain Antibody Platform Market Size by Application (2023-2028) 9.3.3 Latin America Single-Domain Antibody Platform Market Share by Application (2017-2028) 9.4 Latin America Single-Domain Antibody Platform Market Size by Country 9.4.1 Latin America Single-Domain Antibody Platform Market Size by Country (2017-2022) 9.4.2 Latin America Single-Domain Antibody Platform Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil10 Middle East & Africa 10.1 Middle East & Africa Single-Domain Antibody Platform Market Size (2017-2028) 10.2 Middle East & Africa Single-Domain Antibody Platform Market Size by Type 10.2.1 Middle East & Africa Single-Domain Antibody Platform Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Single-Domain Antibody Platform Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Single-Domain Antibody Platform Market Share by Type (2017-2028) 10.3 Middle East & Africa Single-Domain Antibody Platform Market Size by Application 10.3.1 Middle East & Africa Single-Domain Antibody Platform Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Single-Domain Antibody Platform Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Single-Domain Antibody Platform Market Share by Application (2017-2028) 10.4 Middle East & Africa Single-Domain Antibody Platform Market Size by Country 10.4.1 Middle East & Africa Single-Domain Antibody Platform Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Single-Domain Antibody Platform Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE11 Key Players Profiles 11.1 Creative BioLabs A 11.1.1 Creative BioLabs A Company Details 11.1.2 Creative BioLabs A Business Overview 11.1.3 Creative BioLabs A Single-Domain Antibody Platform Introduction 11.1.4 Creative BioLabs A Revenue in Single-Domain Antibody Platform Business (2017-2022) 11.1.5 Creative BioLabs A Recent Developments 11.2 Synbio Technologies 11.2.1 Synbio Technologies Company Details 11.2.2 Synbio Technologies Business Overview 11.2.3 Synbio Technologies Single-Domain Antibody Platform Introduction 11.2.4 Synbio Technologies Revenue in Single-Domain Antibody Platform Business (2017-2022) 11.2.5 Synbio Technologies Recent Developments 11.3 ProSci Incorporated 11.3.1 ProSci Incorporated Company Details 11.3.2 ProSci Incorporated Business Overview 11.3.3 ProSci Incorporated Single-Domain Antibody Platform Introduction 11.3.4 ProSci Incorporated Revenue in Single-Domain Antibody Platform Business (2017-2022) 11.3.5 ProSci Incorporated Recent Developments 11.4 BioCat GmbH 11.4.1 BioCat GmbH Company Details 11.4.2 BioCat GmbH Business Overview 11.4.3 BioCat GmbH Single-Domain Antibody Platform Introduction 11.4.4 BioCat GmbH Revenue in Single-Domain Antibody Platform Business (2017-2022) 11.4.5 BioCat GmbH Recent Developments 11.5 Antibody Design Labs 11.5.1 Antibody Design Labs Company Details 11.5.2 Antibody Design Labs Business Overview 11.5.3 Antibody Design Labs Single-Domain Antibody Platform Introduction 11.5.4 Antibody Design Labs Revenue in Single-Domain Antibody Platform Business (2017-2022) 11.5.5 Antibody Design Labs Recent Developments 11.6 GenScript 11.6.1 GenScript Company Details 11.6.2 GenScript Business Overview 11.6.3 GenScript Single-Domain Antibody Platform Introduction 11.6.4 GenScript Revenue in Single-Domain Antibody Platform Business (2017-2022) 11.6.5 GenScript Recent Developments 11.7 Oak BioSciences, Inc. 11.7.1 Oak BioSciences, Inc. Company Details 11.7.2 Oak BioSciences, Inc. Business Overview 11.7.3 Oak BioSciences, Inc. Single-Domain Antibody Platform Introduction 11.7.4 Oak BioSciences, Inc. Revenue in Single-Domain Antibody Platform Business (2017-2022) 11.7.5 Oak BioSciences, Inc. Recent Developments 11.8 Rockland Immunochemicals, Inc 11.8.1 Rockland Immunochemicals, Inc Company Details 11.8.2 Rockland Immunochemicals, Inc Business Overview 11.8.3 Rockland Immunochemicals, Inc Single-Domain Antibody Platform Introduction 11.8.4 Rockland Immunochemicals, Inc Revenue in Single-Domain Antibody Platform Business (2017-2022) 11.8.5 Rockland Immunochemicals, Inc Recent Developments 11.9 Hybrigenics Services 11.9.1 Hybrigenics Services Company Details 11.9.2 Hybrigenics Services Business Overview 11.9.3 Hybrigenics Services Single-Domain Antibody Platform Introduction 11.9.4 Hybrigenics Services Revenue in Single-Domain Antibody Platform Business (2017-2022) 11.9.5 Hybrigenics Services Recent Developments 11.10 NeoClone Biotechnology International LLC 11.10.1 NeoClone Biotechnology International LLC Company Details 11.10.2 NeoClone Biotechnology International LLC Business Overview 11.10.3 NeoClone Biotechnology International LLC Single-Domain Antibody Platform Introduction 11.10.4 NeoClone Biotechnology International LLC Revenue in Single-Domain Antibody Platform Business (2017-2022) 11.10.5 NeoClone Biotechnology International LLC Recent Developments 11.11 Kaneka Eurogentec S.A 11.11.1 Kaneka Eurogentec S.A Company Details 11.11.2 Kaneka Eurogentec S.A Business Overview 11.11.3 Kaneka Eurogentec S.A Single-Domain Antibody Platform Introduction 11.11.4 Kaneka Eurogentec S.A Revenue in Single-Domain Antibody Platform Business (2017-2022) 11.11.5 Kaneka Eurogentec S.A Recent Developments 11.12 ProteoGenix 11.12.1 ProteoGenix Company Details 11.12.2 ProteoGenix Business Overview 11.12.3 ProteoGenix Single-Domain Antibody Platform Introduction 11.12.4 ProteoGenix Revenue in Single-Domain Antibody Platform Business (2017-2022) 11.12.5 ProteoGenix Recent Developments12 Analyst's Viewpoints/Conclusions13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer